— Know what they know.
Not Investment Advice

603658.SS SHH

Autobio Diagnostics Co., Ltd.
1W: -2.5% 1M: +3.5% 3M: +13.0% YTD: -6.9% 1Y: -16.8% 3Y: -33.9% 5Y: -50.3%
¥34.08 ($5.08)
+0.47 (+1.40%)
 
SHH · Healthcare · Medical - Specialties · Tech Score Buy · Power 61 · ¥19.5B mcap · 161M float · 2.09% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥19.5B ($2.9B)
52W Range28.18-39.8
Volume3,547,968
Avg Volume3,369,689
Beta-0.02
Dividend¥1.31
Analyst Ratings
No analyst coverage
Company Info
CEOZeng Li Yang
Employees5,700
SectorHealthcare
IndustryMedical - Specialties
IPO Date2016-09-02
No. 199, 15th Avenue
Zhengzhou, HN 450016
CN
86 40 0056 9995
About Autobio Diagnostics Co., Ltd.

Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents for immunoassay, biochemistry, microbiology, and in-vitro diagnostics (IVD). Additionally, they provide advanced automated and semi-automated instrumentation, alongside comprehensive medical laboratory solutions. Notable immunoassay products include the AutoLumo A2000 Plus automatic chemiluminescence immunoassay analyzer, automated microplate chemiluminescent enzyme immunoassays, LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Within their microbiology division, they offer automated blood culture systems, blood culture bottles, AUTOMIC strips, and mycoplasma IES. Founded in 1998, the company originally operated as Lifeclone Diagnostics Co., Ltd. before adopting its current name, Autobio Diagnostics Co., Ltd., in 2003. Headquartered in Zhengzhou, China, it functions as a subsidiary of Zhengzhou Auto Industrial Co., Ltd.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms